Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Refractory Diffuse Large B Cell Lymphoma (DLBCL)
View Full LandscapeTarget Indication
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Clinical Trial
NCT02348216Last updated: 3/6/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Pre-Exposure Prophylaxis of HIV Infection
HIV Infections
HIV-1 Infection
Cystic Fibrosis
Locally Advanced or Metastatic Unresectable Urothelial Cancer